Special Considerations and Clinical Management of HIV-Infected Drug Users

  • Author: Frederick L. Altice, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)

Summary

    Prevention and Risk Reduction
    • Reduction in drug-use frequency and safer injection practices are more realistic goals than complete cessation for many drug users until abstinence can be achieved
    • Provision of drug-use paraphernalia and education are essential to HIV risk–prevention services for drug users (Management Guidelines)[CDC Intervention]
    • PWIDs should be routinely screened for HBV, HCV, latent TB infection, syphilis, and other STDs, and offered pneumococcal, influenza, tetanus, and HBV immunization, and (when appropriate) prophylaxis for TB (Management Guidelines)[Aberg 2014]
    HIV Prevention

    Action required